EVOLUTION OF NUTRITION SCIENCE

Phase I: Macronutritents
    -Protein, fat, carbohydrates    
    -Function at the basic physiological level

Phase II:  Micronutritents    
    -Vitamins, minerals
    -Function at the systemic level
    -Basis for 20th century nutrition research

Phase III: Bioactive Compounds   
   -Phytochemicals, peptides, isoflavones
   -Function at the epigenetic level
   -Nutrition-medical Innovation for the 21st Century

 

Lunasin is the first bioactive compound proven to affect gene espression and promote optimal health at the epigenetic level.

Product Quality: US Manufacturing Plant and FDA

1996:   Lunasin discovered by Dr. Alfredo Galvez at UC Berkeley

1999:   FDA approves heart health claim for soy protein

Reliv: Who we are

2008:  Dr. Galvez presents lunasin's epigenetic mechanism of action for lowering cholesterol 

2009:  Soy Labs awarded US patent for mechanism of action

2011:    Missouri Plant Science Center opens, Reliv partners with Soy Labs and MPSC.  

Reliv International, a publicly held food science company whose manufacturing and research is out of St Louis Missouri.  This is their 25th year in business, has 6 patented formulations, and  many clinical trials.

The MPSC is a truly novel concept. Through an unprecedented collaboration among universities, industry and government, the Center is designed to provide companies with a platform to encourage innovation and aggressive growth. As such, the MPSC rivals any facility of its kind in the world.

Through its partnership with the Center, Reliv will gain greater access to:

  • the latest soy and plant biotechnology research
  • government, university and corporate partner resources
  • opportunities for Reliv clinical studies
  • industry and mainstream media exposure
  • exclusive ingredient innovations

Further studies and research will be coming out over the next few months.


2012: Reliv introduces LunaRich® soy powder by adding them to some of their products


2012:  Dr Galvez presents the lunasin research in front of the American Heart Association's conference

2013:   Reliv launches LunaRich X capsules for concentrated form and easy to use

2013:   Reliv announces exclusive rights to is the lunasin produced through a proprietary extraction process developed by Soy Labs. No one else has been able to effectively extract bioactive lunasin of such quality and in such concentration. Reliv is now way ahead of the curve in harnessing the power of this clinically proven superfood.


 Independent Reliv Distributors since 1993